SCHEMBL17828815

SCHEMBL17828815

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c6ccccc6n(-c6cccc(-c7nc(-c8cccc9ccccc89)c8ccc9ccccc9c8n7)c6)c5c4)ccc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
ATM Q13315 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 4/20 0.33
MAPT P10636 2/20 0.33
PTGER4 P35408 1/20 0.33
CYP1A1 P04798 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP1B1 Q16678 1/20 0.32
PDE10A Q9Y233 1/20 0.31
F2 P00734 1/20 0.31
F10 P00742 1/20 0.31
PRSS1 P07477 1/20 0.31
TP53 P04637 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
MAPK1 P28482 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18264757 0.98 KDM4E (0.36) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL17829026 0.94 KDM4E (0.35) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL17828833 0.93 ATM (0.37) KDM4EATML3MBTL1PTGER4CYP1A1
SCHEMBL17828921 0.93 ATM (0.37) KDM4EATML3MBTL1PTGER4CYP1A1
SCHEMBL18264770 0.92 KDM4E (0.35) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL17829014 0.92 KDM4E (0.36) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL17828805 0.92 ATM (0.36) KDM4EATML3MBTL1PTGER4CYP1A1
SCHEMBL17828857 0.92 ALDH1A1 (0.34) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL17828882 0.92 ALDH1A1 (0.34) KDM4EATML3MBTL1ALDH1A1MAPT
SCHEMBL17828998 0.91 ATM (0.37) KDM4EATML3MBTL1PTGER4CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 KDM4E 2236/4885ATM 2921/4885L3MBTL1 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.